Amanote Research
Register
Sign In
Elaboration of Type B Capsule by Haemophilus Influenzae as a Determinant of Pathogenicity and Impaired Killing by Trimethoprim-Sulfamethoxazole.
Journal of Clinical Investigation
- United States
doi 10.1172/jci110493
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Date
March 1, 1982
Authors
R Yogev
E R Moxon
Publisher
American Society for Clinical Investigation
Related search
MOBILIZATION OF TYPE B CAPSULE GENE(S) IN HAEMOPHILUS INFLUENZAE B (Hib) BY CELL TO CELL CONTACT
Pediatric Research
Child Health
Pediatrics
Perinatology
Synthesis and Release of Polyribophosphate by Haemophilus Influenzae Type B in Vitro.
Infection and Immunity
Parasitology
Infectious Diseases
Immunology
Microbiology
Type II Hypersensitivity and Trimethoprim-Sulfamethoxazole
Pediatric Review: International Journal of Pediatric Research
Bactericidal Factor Produced by Haemophilus Influenzae B: Partial Purification of the Factor and Transfer of Its Genetic Determinant
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Haemophilus Influenzae Type B Antigenuria in Children.
Journal of Clinical Pathology
Medicine
Forensic Medicine
Pathology
Chemoprophylaxis for Haemophilus Influenzae Type B: Authors' Reply
BMJ
Maternal and Neonatal Sepsis Caused by Haemophilus Influenzae Type D
Journal of Medical Microbiology
Medicine
Microbiology
Trimethoprim and Rifampin in Combination for Chemoprophylaxis of Household Contacts of Patients With Invasive Infections Due to Haemophilus Influenzae Type B.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
The V-Region Repertoire of Haemophilus Influenzae Type B Polysaccharide Antibodies Induced by Immunization of Infants.
Infection and Immunity
Parasitology
Infectious Diseases
Immunology
Microbiology